BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Sep 15, 2026; 18(9): 117864
Published online Sep 15, 2026. doi: 10.4251/wjgo.117864
Table 1 Comparison of baseline characteristics between the two groups, n (%)
Indicator
Study group (n = 80)
Control group (n = 80)
t/χ2
P value
Gender1.6160.204
    Male 48 (60.00) 40 (50.00)
    Female 32 (40.00) 40 (50.00)
Age (years) 58.42 ± 10.1258.90 ± 9.870.3040.762
BMI (kg/m2) 24.36 ± 3.1224.58 ± 3.050.4510.653
Surgical type0.2270.634
    Gastric ESD35 (43.75) 38 (47.50)
    Intestinal ESD45 (56.25) 42 (52.50)
Maximum tumor diameter (cm)1.85 ± 0.781.90 ± 0.820.3950.693
ASA classification1.9110.385
    Grade I50 (62.50) 58 (72.50)
    Grade II25 (31.25) 19 (23.75)
    Grade III5 (6.25) 3 (3.75)
NRS 2002 score (points) 1.25 ± 0.681.32 ± 0.710.6370.525
History of gastrointestinal disease 22 (27.50) 18 (22.50) 0.5330.465
Use of anticoagulants/antiplatelet agents9 (11.25) 12 (15.00) 0.4930.482


Write to the Help Desk